Transgenic model evaluation II (Benzene): Target Organs and Levels of Evidence for GMM-08
GMM-08 Toxicology and Carcinogenesis Study of Benzene (CASRN 71-43-2) in Genetically Modified Haploinsufficient p16Ink4a/p19Arf Mice (Gavage Study)
Chemical (Study Title) CASRN | Peer Review Date | Route/Exposure Levels | Study Laboratory |
---|---|---|---|
Transgenic model evaluation II (Benzene) 71-43-2 | 08/28/2006 | Gavage 0, 25, 50, 100, or 200 mg/kg | Battelle Columbus Laboratory |
Male Haploinsufficient p16Ink4a/p19Arf Mice | Female Haploinsufficient p16Ink4a/p19Arf Mice | |
---|---|---|
27 Week | 27 Week | |
Levels of Evidence | Clear Evidence | No Evidence |
Neoplastic Lesions |
| None |
Non-Neoplastic Lesions |
|
|